BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1899831)

  • 1. Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon.
    Hahn T; Barak Y; Liebovich E; Malach L; Dagan O; Rubinstein E
    Exp Hematol; 1991 Mar; 19(3):157-60. PubMed ID: 1899831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
    Wang CQ; Udupa KB; Lipschitz DA
    J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
    Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE
    J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
    Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
    J Cell Biochem; 1989 Feb; 39(2):107-15. PubMed ID: 2715197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.
    Barak Y; Hahn T; Pecht M; Karov Y; Berrebi A; Zaizov R; Stark B; Buchner V; Burstein Y; Trainin N
    Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
    Murphy M; Perussia B; Trinchieri G
    Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
    Lu L; Welte K; Gabrilove JL; Hangoc G; Bruno E; Hoffman R; Broxmeyer HE
    Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
    J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
    Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
    J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
    Jacobsen SE; Ruscetti FW; Ortiz M; Gooya JM; Keller JR
    Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
    Totpal K; Aggarwal BB
    Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor.
    Pelus LM; Ottmann OG; Nocka KH
    J Immunol; 1988 Jan; 140(2):479-84. PubMed ID: 3121745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
    Kawano Y; Takaue Y; Hirao A; Sato J; Abe T; Suzue T; Saito S; Okamoto Y; Kuroda Y
    Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.